REMIT-iGlarLixi: Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches – results of a randomised controlled trial
- Homepage
- >
- Publications
- >
- REMIT-iGlarLixi: Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches – results of a randomised controlled trial
